Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP was delisted on the 13th of August, 2018.
36 hedge funds and large institutions have $20.9M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
16% more funds holding
Funds holding: 31 → 36 (+5)
15% more capital invested
Capital invested by funds: $18.2M → $20.9M (+$2.69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
+$958K |
| 2 |
Renaissance Technologies
New York
|
+$422K |
| 3 |
AG
Algert Global
San Francisco,
California
|
+$366K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$300K |
| 5 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$299K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$729K |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$255K |
| 3 |
BlackRock
New York
|
-$133K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$124K |
| 5 |
SIM
Spark Investment Management
New York
|
-$59.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $60K | +$59.9K | +12,322 | New |
|
27
Citadel Advisors
Miami,
Florida
| $50K | +$50.6K | +10,404 | New |
|
|
BGIM
28
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
| $21K | +$20.4K | +4,200 | New |
|
29
UBS Group
Zurich,
Switzerland
| $18K | +$17.4K | +3,570 | +2,856% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $15K | +$734 | +151 | +5% |
|
31
Federated Hermes
Pittsburgh,
Pennsylvania
| $8K | +$7.73K | +1,590 | New |
|
|
GFP
32
Gryphon Financial Partners
Columbus,
Ohio
| $5K | +$4.86K | +1,000 | New |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | -$30.4K | -6,250 | -91% |
|
|
FWM
34
Focused Wealth Management
Newburgh,
New York
| $1K | – | – | – |
|
|
NFA
35
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$255K | -56,000 | Closed |
|
36
Bank of New York Mellon
New York
| – | -$50K | -10,958 | Closed |
|
37
Simplex Trading
Chicago,
Illinois
| – | -$6K | -1,437 | Closed |
|
|
DCM
38
Delpha Capital Management
New York
| – | +$486 | +100 | New |
|
JNP Hedge Fund Activity: Q4 2017 in Review
36 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) for Q4 2017, worth a combined $20.9M — up 15% from $18.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new JNP positions and 3 closed out — a net gain of 5 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Krensavage Asset Management, adding an estimated $958K. The largest seller was Heartland Advisors, cutting an estimated $729K.
- 36 institutional investors held Juniper Pharmaceuticals, Inc. Common Stock (JNP) as of Q4 2017, up from 31 in Q3 2017.
- Funds reported $20.9M of Juniper Pharmaceuticals, Inc. Common Stock stock for Q4 2017, up 15% quarter-over-quarter.
- 8 funds opened new Juniper Pharmaceuticals, Inc. Common Stock positions in Q4 2017 and 3 closed out, a net change of +5 holders.
- The largest Juniper Pharmaceuticals, Inc. Common Stock buyer in Q4 2017 was Krensavage Asset Management, an estimated $958K added.
- The largest Juniper Pharmaceuticals, Inc. Common Stock seller in Q4 2017 was Heartland Advisors, an estimated $729K sold.
Based on aggregated 13F filings for Q4 2017.